Unconfigured Ad

Collapse

Any non-primary sequence heritable modification of genetic material. ChIP-SEQ, DNA methylation (Bisulfite-SEQ), chromatin modifications (methylation, acetylation, etc), non coding RNA.

Forums Topics Posts Last Post
No forums found.
  •  
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by ECO, 11-03-2008, 12:50 AM
20 responses
88,811 views
0 reactions
Last Post sameet
by sameet
 
Started by ecSeq Bioinformatics, 10-19-2025, 10:34 PM
0 responses
125 views
0 reactions
Last Post ecSeq Bioinformatics  
Started by Yasmina_yas, 06-28-2025, 04:03 AM
0 responses
153 views
0 reactions
Last Post Yasmina_yas  
Started by adrilmelx, 02-02-2025, 01:28 PM
0 responses
190 views
0 reactions
Last Post adrilmelx  
Started by crazyhottommy, 12-09-2023, 09:17 PM
0 responses
518 views
0 reactions
Last Post crazyhottommy  
Started by dznat, 02-21-2023, 12:45 PM
0 responses
219 views
0 reactions
Last Post dznat
by dznat
 
Started by malonzm1, 08-25-2022, 11:38 PM
0 responses
315 views
0 reactions
Last Post malonzm1  
Started by metheuse, 07-13-2022, 04:40 PM
0 responses
136 views
0 reactions
Last Post metheuse  
Started by malonzm1, 03-30-2022, 05:34 PM
0 responses
2,748 views
0 reactions
Last Post malonzm1  
Started by kpet, 06-17-2020, 02:55 AM
1 response
9,995 views
0 reactions
Last Post samareen  
Started by bbm, 09-16-2013, 08:07 AM
15 responses
12,859 views
0 reactions
Last Post BioDynami  
No topics found.
  • Time
Clear All
No photos found.
  • Time
Clear All

Webinars

Collapse

Recent Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 10:13 AM
0 responses
13 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Working...